Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “mTOR”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01449955
What this trial is testing

Rapamycin as a Means of Interference With Reconsolidation of Posttraumatic Stress Disorder-related Traumatic Memory

Who this might be right for
Posttraumatic Stress Disorder
University of Texas Southwestern Medical Center 54
Early research (Phase 1)WithdrawnNCT00352950
What this trial is testing

Safety Evaluation of Panitumumab and Sirolimus in Advanced Non-Small Cell Lung Cancer

Who this might be right for
OncologyNon-Small Cell Lung Cancer
Amgen
Testing effectiveness (Phase 2)Ended earlyNCT01582009
What this trial is testing

Panobinostat and Everolimus in Treating Patients With Metastatic or Unresectable Renal Cell Cancer That Does Not Respond to Treatment With Sunitinib Malate or Sorafenib Tosylate

Who this might be right for
Clear Cell Renal Cell CarcinomaRecurrent Renal Cell CancerStage III Renal Cell Cancer+1 more
Roswell Park Cancer Institute 26
Early research (Phase 1)Study completedNCT02684032
What this trial is testing

Assess The Tolerability And Clinical Activity Of Gedatolisib In Combination With Palbociclib/Letrozole Or Palbociclib/Fulvestrant In Women With Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Celcuity Inc 141
Early research (Phase 1)Study completedNCT01033721
What this trial is testing

Phase I Study of Palomid 529 a Dual TORC1/2 Inhibitor of the PI3K/Akt/mTOR Pathway for Advanced Neovascular Age-Related Macular Degeneration

Who this might be right for
Age-Related Macular Degeneration
Paloma Pharmaceuticals, Inc. 13
Not applicableStudy completedNCT02441543
What this trial is testing

Regulation of Lymphocyte Anti-tumor Response in Metastatic Patients Treated With the mTOR Inhibitor Everolimus

Who this might be right for
SOLID TUMOR
Istituto Clinico Humanitas 45
Testing effectiveness (Phase 2)Study completedNCT01075321
What this trial is testing

Everolimus and Lenalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin or Hodgkin Lymphoma

Who this might be right for
Adult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+16 more
Mayo Clinic 58
Early research (Phase 1)Study completedNCT01195376
What this trial is testing

BEZ235 in Adult Japanese Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
Novartis Pharmaceuticals 35
Testing effectiveness (Phase 2)Study completedNCT00985192
What this trial is testing

Everolimus in Treating Patients With Previously Treated Unresectable or Metastatic Esophageal Cancer or Stomach Cancer

Who this might be right for
Esophageal CancerGastric Cancer
Translational Oncology Research International 49
Testing effectiveness (Phase 2)Looking for participantsNCT06463028
What this trial is testing

Sapanisertib and Serabelisib (PIKTOR) With Paclitaxel and a Substudy With an Insulin-Suppressing Diet in Patients With Advanced/Recurrent Endometrial Cancer

Who this might be right for
Endometrial Cancer
Faeth Therapeutics 40
Large-scale testing (Phase 3)Study completedNCT03176238
What this trial is testing

Study in Post-menopausal Women With Hormone Receptor Positive, HER2-negative Advanced Breast Cancer

Who this might be right for
Post Menopausal Breast Cancer
Novartis Pharmaceuticals 235
Very early researchLooking for participantsNCT06719791
What this trial is testing

Sirolomus Adjuvant Treatment of Focal Refractory Epilepsy (SATFRE)

Who this might be right for
Epilepsy, Drug Resistant
Xuanwu Hospital, Beijing 15
Not applicableStudy completedNCT04206124
What this trial is testing

MTORC1 and Autophagy in Human Brown Adipocytes

Who this might be right for
ObesityMetabolic Disease
University of New Mexico 24
Large-scale testing (Phase 3)Ended earlyNCT01633060
What this trial is testing

A Phase III Study of BKM120 With Fulvestrant in Patients With HR+,HER2-, AI Treated, Locally Advanced or Metastatic Breast Cancer Who Progressed on or After mTORi

Who this might be right for
Metastatic Breast Cancer
Novartis Pharmaceuticals 432
Early research (Phase 1)Study completedNCT00927823
What this trial is testing

A Trial To Assess Safety And Tolerability Of PF-04691502 In Cancer Patients

Who this might be right for
Cancer
Pfizer 37
Testing effectiveness (Phase 2)WithdrawnNCT03290963
What this trial is testing

Effect of Lithium Versus Placebo in Adults With Treatment-Resistant Depression Who Are Receiving Ketamine

Who this might be right for
Treatment Resistant Depression
William V. Bobo, M.D.
Not applicableLooking for participantsNCT04395495
What this trial is testing

RASopathy Biorepository

Who this might be right for
RAS MutationNeurofibromatosis 1Noonan Syndrome+11 more
Children's Hospital Medical Center, Cincinnati 1,000
Large-scale testing (Phase 3)Study completedNCT01028092
What this trial is testing

MTor-inhibitor (EVERolimus) Based Immunosuppressive Strategies for CNI Minimisation in OLD for Old Renal Transplantation

Who this might be right for
Renal Transplant
University Hospital, Brest 327
Large-scale testing (Phase 3)UnknownNCT03580239
What this trial is testing

Everolimus in Castrated Resistant Prostate Cancer(CRPC)Patients With PI3K-AKT-mTOR Signaling Pathway Deficiency

Who this might be right for
Prostate Cancer
Tianjin Medical University Second Hospital 120
Early research (Phase 1)Study completedNCT04774952
What this trial is testing

Dose Escalation of RMC-5552 Monotherapy in Relapsed/Refractory Solid Tumors

Who this might be right for
Solid Tumors
Revolution Medicines, Inc. 58
Next Page